As per a recently concluded study, it was revealed that children being administered with inhaled corticosteroids such as budesonide in the past have not been able to show those improvements after stopping the steroid treatment. These results were observed after the Childhood Asthma Management Program (CAMP) clinical trial announced its findings on more than 1,000 children in the age group of 5-12 years.

During the study, it was found that children (now in their late teens) who have been advised steroid therapy in the past and stopped now showed no differences in management of asthma when they were compared with children who received the placebo.

Robert C. Strunk, M.D., a Washington University pediatrician at St. Louis Children’s Hospital and lead author of the study, said that it was quite interesting to note that children tend to do better with the passe of age when it comes to combating asthma.

Inhaled corticosteroids such as budesonide have been regarded as one of the most effective forms of anti-inflammatory treatments for controlling asthma via improving pulmonary function.

From Sciencedaily.com:

“While the kids did get better with age and didn’t seem to need the medicine as much, laboratory measurements indicated that they were still having symptoms, and therefore were primed to an attack if they got a bad cold or were exposed to a significant weather change,” Strunk said.

The researchers determined that continued benefit of these medications likely requires continued use.

“The conclusion is that some kids get better, but the doctor, family and the patient have to pay attention to the symptoms,” Strunk said. “Some of the kids are going to need medicine, and they have to be honest about that possibility.”

In another part of the follow-up study, researchers looked at long-term side effects of the steroid medications on growth, bone density and fracture rate. The only side effect of budesonide was a 0.4-inch decrease in height among female patients compared to the patients who took a placebo during the trial. However, one-fourth of the girls and more than half of the boys in the trial had not reached final adult height at the end of the post-trial period, researchers said. There were no effects of the nedocromil treatment on growth.

Funding from the National Heart, Lung, and Blood Institute and the National Center for Research Resources supported this research.

The study also suggested that if an asthma patient gets cured after being administered with steroid treatment then he should not stop the treatment presuming that asthma is completely cured. It was found that continued benefits of steroid medications require continued usage.